Insight

Aurélien Marabelle: Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology

Aurélien Marabelle/edimark.fr

Dec 15, 2024, 01:24

Aurélien Marabelle: Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology

Aurélien Marabelle, Medical Oncologist at Gustave Roussy and Professor of Clinical Immunology at Paris-Saclay University, shared a recent article on LinkedIn:

“Subtle differences in antibody engineering can make big impacts on treatment efficacy and patient safety.

Check out our latest review on Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology if you want to learn more.”

Title: Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology

Authors: Romane Martineau, Sandrine Susini and Aurelien Marabelle

Aurélien Marabelle

For more updates, follow OncoDaily.

Antibodies in Oncology antibody engineering Aurélien Marabelle cancer Fc Effector Function OncoDaily Oncology patient safety Romane Martineau Sandrine Susini

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage